[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Scherberich et al., 1985 - Google Patents

Monitoring drug nephrotoxicity

Scherberich et al., 1985

Document ID
14029890799105206540
Author
Scherberich J
Mondorf W
Falkenberg F
Pierard D
Schoeppe W
Publication year
Publication venue
Kidney, Small Proteins and Drugs: 3rd International Symposium of Nephrology, Montecatini Terme, May 1983

External Links

Snippet

The brush border (BB) of the proximal tubule from human kidney, involved in transepithelial movement of solutes, amino acids, peptides, and small proteins such as glucagon, insulin, angiotensin, a₁-and ẞ2-microglobulin, exhibits typical ultrastructural and biochemical …
Continue reading at books.google.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology

Similar Documents

Publication Publication Date Title
Edgington et al. Autologous immune complex nephritis induced with renal tubular antigen: I. Identification and isolation of the pathogenetic antigen
Taylor et al. Autoimmune phenomena in pernicious anaemia: gastric antibodies
Cole et al. A specific soluble substance involved in nephrotoxic nephritis.
Bonomo et al. Abdominal lymphoma and alpha chain disease: Report of three cases
Daniele et al. Immune complexes in sarcoidosis: a correlation with activity and duration of disease
Chisari Regulation of human lymphocyte function by a soluble extract from normal human liver
Harboe et al. Antigenic heterogeneity of Waldenström type γM‐globulins
Zabriskie The role of streptococci in human glomerulonephritis
Mohos et al. Insulin-induced glomerulosclerosis in the rabbit
Eknoyan et al. Renal involvement in drug abuse
Herman et al. Response of the rheumatoid synovial membrane to exogenous immunization
Irie et al. Detection of antibody and complement complexed in vivo on membranes of human cancer cells by mixed hemadsorption techniques
US4299814A (en) Radioimmunoassay of MIF
JPH07278194A (en) L1 protein
Scherberich et al. Monitoring drug nephrotoxicity
RODRÍGUEZ-ITURBE et al. Characterization of the glomerular antibody in acute poststreptococcal glomerulonephritis
Jepson et al. Decreased in vivo and in vitro erythropoiesis induced by plasma of ten patients with thymoma, lymphosarcoma, or idiopathic erythroblastopenia
Osserman et al. The plasma proteins in liver disease
Loegering et al. Depressing hepatic macrophage complement receptor function causes increased susceptibility to endotoxemia and infection
Choi et al. DEVELOPMENT OF CHICKEN LYMPHOID SYSTEM: I. Synthesis and Secretion of Immunoglobulins by Chicken Lymphoid Cells
Jacob et al. Localization of intrinsic factor and complement fixing intrinsic factor–intrinsic factor antibody complex in parietal cell of man
Berger et al. Cirrhotic hyperglobulinemia: increased rates of immunoglobulin synthesis by circulating lymphoid cells
DE68926245T2 (en) DETECTION OF THE BASE MEMBRANE COMPONENTS, DIAGNOSIS OF CANCER AND OTHER DISEASES
Williams Jr et al. Lymphocyte surface markers in acute rheumatic fever and post-streptococcal acute glomerulonephritis.
CH636449A5 (en) Method for obtaining a new specific alpha-l-antikoerpers.